Allergies
Date: | 06-Jul-16 to 07-Jul-16 |
Location: | Holiday Inn Kensington Forum / London / United Kingdom |
Category: | Food & Beverages Healthcare & Pharmaceuticals Science Conferences & Trade Fairs World & Regional |
SMi Group is thrilled to present the 3rd annual Allergies conference taking place on 6 - 7 July 2016 in London, UK. Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide the perfect platform to discuss pioneering clinical developments and the next generation of allergy therapeutics.
Created with a top panel of industry thought leaders, this year's event will look to capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus more.
Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes.
SPEAKERS INCLUDE:
• Carl Dolman, Immunoglobulins & Allergen Study, Director, NIBSC, MHRA
• Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research
• Jean Cuine, Global Head of Non-Clinical and Pharmaceutical Development, Stallergenes Greer
• Dirk-Jan Opstelten, R&D Director, HAL Allergy
• Thierry Batard, Senior Dir. Innovation & Technological Platforms, Stallergenes Greer
• Tim Higenbottam, R&D Director, Allergy Therapeutics
• Karen Knipping, Senior Scientist, Danone Nutricia Research
• Sophie Nutten, Group Leader of the Allergy Group, Nestle Research Centre
• Kimihiro Okubo, Dept of Otorhinolaryngology, Nippon Medical School
REASONS TO ATTEND:
• Learn about sublingual immunotherapy for cedar pollinosis and mite
• Hear the latest updates on regulation and clinical trials for paediatric immunotherapy
• Obtain an overview of the development of allergen-specific immunotherapy for allergic rhinitis and food allergy
• Discover the nutritional approaches for primary prevention of allergic disease
Visit the website for further details and early bird rates at
http://www.allergies-event.com/ein
Created with a top panel of industry thought leaders, this year's event will look to capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus more.
Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes.
SPEAKERS INCLUDE:
• Carl Dolman, Immunoglobulins & Allergen Study, Director, NIBSC, MHRA
• Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research
• Jean Cuine, Global Head of Non-Clinical and Pharmaceutical Development, Stallergenes Greer
• Dirk-Jan Opstelten, R&D Director, HAL Allergy
• Thierry Batard, Senior Dir. Innovation & Technological Platforms, Stallergenes Greer
• Tim Higenbottam, R&D Director, Allergy Therapeutics
• Karen Knipping, Senior Scientist, Danone Nutricia Research
• Sophie Nutten, Group Leader of the Allergy Group, Nestle Research Centre
• Kimihiro Okubo, Dept of Otorhinolaryngology, Nippon Medical School
REASONS TO ATTEND:
• Learn about sublingual immunotherapy for cedar pollinosis and mite
• Hear the latest updates on regulation and clinical trials for paediatric immunotherapy
• Obtain an overview of the development of allergen-specific immunotherapy for allergic rhinitis and food allergy
• Discover the nutritional approaches for primary prevention of allergic disease
Visit the website for further details and early bird rates at
http://www.allergies-event.com/ein
Visitors
Chief, Vice Presidents, Heads, Senior Directors, Directors, Principals, Team Leaders, Clinicans of:
Immunotherapy Drug Discovery
Medical Officer
Scientific Officer
Allergy Medicine/ Therapeutics
Allergy Pharmacology
Immunotherapy
Pharmacology
Inflammation and Autoimmunity
from pharmaceuticals & biotech companies, hospitals and academics.
Immunotherapy Drug Discovery
Medical Officer
Scientific Officer
Allergy Medicine/ Therapeutics
Allergy Pharmacology
Immunotherapy
Pharmacology
Inflammation and Autoimmunity
from pharmaceuticals & biotech companies, hospitals and academics.
Exhibitors
Service Providers. Confirmed sponsors include DBV Technologies, Indoor Biotechnologies, Inflamax Research
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Beverage Industry Today
- Brain Cancer News Today
- Brazil Business Today
- Breast Cancer News Today
- Breastfeeding News Today
- CNES News Today
- Canadian Space Agency News Today
- Central Europe Online
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- Fast Food News Today
- Food & Drug Administration News Today
- Food Industry Today
- Food Safety News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Inside China Today
- JAXA News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- NASA News Today
- Organic Food News Today
- Pharmaceutical Industry Today
- Pink Slime News Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- Research Reports News Today
- Restaurant Industry Today
- SARS News Today
- Science News Today
- Sea Piracy News Today
- Seafood News Today
- Supermarket News Today
- The Russia News Service
- Trans-Pacific Partnership News Today
- Wellness News Today
- World News Report